Skip to main content
logo
Mereo BioPharma Group plc (LON:0A9G)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.2795
-0.0069 (-2.41%)
At close: Sep 14, 2026

Mereo BioPharma Group Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
334943325473128
Market Cap Growth
-84.18%-88.62%70.57%249.41%-43.41%-27.46%
Enterprise Value
12133742211437
Last Close Price
0.210.272.761.850.621.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----10.09
PS Ratio
-132.62-32.34-3.52
PB Ratio
1.531.628.896.401.701.46
P/TBV Ratio
1.541.648.996.541.702.02

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-36.02-28.17-1.02

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.010.110.120.300.19
Net Debt / Equity Ratio
-1.01-1.00-1.04-1.02-1.03-0.88
Net Debt / EBITDA Ratio
0.901.081.401.941.013.72
Net Debt / FCF Ratio
1.151.321.932.441.0813.43
Asset Turnover
-0.01-0.14-0.39
Quick Ratio
5.649.995.286.452.897.66
Current Ratio
5.8810.475.406.723.097.92
Return on Equity (ROE)
-67.85%-82.21%-77.58%-57.81%-53.63%34.85%
Return on Assets (ROA)
-42.46%-39.10%-39.99%-23.57%-28.67%-13.82%
Return on Invested Capital (ROIC)
-----825.95%-57.30%
Return on Capital Employed (ROCE)
-113.90%-91.90%-73.10%-47.60%-99.40%-18.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-64.05%-63.15%-7.98%-9.11%-48.22%9.91%
FCF Yield
-57.78%-46.74%-6.06%-6.54%-55.78%-4.50%
Buyback Yield / Dilution
-2.30%-7.77%-12.16%-9.33%-8.63%-63.82%